Week 16: Closing Out 10mg
Four weeks at 10mg complete. With a full cycle behind you, the dose's contribution is fully visible — and the decision about 12.5mg is ready to be made with data instead of optimism.
The standard prescribing pattern allows titration from 10mg to 12.5mg after at least four weeks at the lower dose. That window opens at week 17. The week-16 question is not whether the window opens — it does — but whether moving up is the right call for your specific trajectory.
For users whose loss is still steady at 10mg with no troublesome side effects, staying at 10mg for another cycle is a routine option and often the better one. 10mg is a clinically effective maintenance-track dose. Moving up earns its place when the trend flattens, weight remains far from goal, or appetite return on injection day starts to interfere with intake control.
Appetite Suppression
Stable. Late-injection-week creep, if it appears, is the most common signal that the dose is starting to underdeliver.
Typical weekly loss continues. Four-month cumulative loss commonly lands between 14 and 18 percent of starting body weight.
Week 16 Timeline
The Week 16 Timeline
Day 106 (Injection 16)
Fourth 10mg Dose
Your final scheduled dose at 10mg before the next titration window opens. Inject as routine; nothing about this dose itself is different.
Days 108-110
Four-Month Data Pull
Gather the full picture: starting weight, current weight, waist, blood pressure, A1C if available, and a clear sense of how 10mg has performed versus 7.5mg.
Day 112
Next Dose Decision
Move to 12.5mg, stay at 10mg, or — if side effects have been hard — drop back. All three are routine. The data is what makes the choice easy.
Navigating Symptoms
If 10mg is comfortable and the trend is intact, you can stay here as long as you and your prescriber agree. There is no requirement to climb to the maximum dose.
This is also a good week for the second labs check of the journey. A1C, fasting lipids, liver enzymes, and a basic metabolic panel give a quantitative picture of how the medication is working beyond the scale. Tirzepatide commonly improves several of these markers meaningfully over four months.
What Users Report
“Four months in, down 36 pounds, A1C 5.2, lipids better than they have been in a decade. Staying at 10mg — no reason to push further yet.”
— Renata M.
“Asked for 12.5mg because the weekly loss had slowed to under a pound and I have 40 more to lose. Doctor agreed. Excited and a little nervous.”
— Wesley B.
Looking ahead
Week 17 either begins 12.5mg or holds at 10mg, depending on the decision made this week. Continue to the week 17 guide for what to expect with the next step up.